Thermo Fisher Scientific (NYSE: TMO) last traded at $629.27, up 0.27% on the session. The quote above updates while this page is open; the figures below are drawn from Thermo Fisher Scientific’s own filings and are restated only when a new one is published.
Thermo Fisher Scientific trades on NYSE under the ticker TMO. It is classified in the Healthcare sector, Life Sciences industry. Its market capitalisation is $232.67 billion.
Healthcare sectorLife SciencesListed on NYSE
Valuation measures for Thermo Fisher Scientific, derived from the latest quote and its most recent SEC filing.
| Market cap | $232.67B |
|---|---|
| P/E ratio | 33.85 |
| Price / sales | 5.02 |
| Price / book | 4.42 |
| Beta | 0.58 |
Trailing-twelve-month figures tagged in Thermo Fisher Scientific's XBRL filings with the SEC.
| Revenue (TTM) | $46.34B |
|---|---|
| Net income (TTM) | $6.97B |
| EPS (TTM) | $18.59 |
| Operating margin | 17.58% |
| Return on equity | 13.23% |
| Cash | $4.06B |
Range and volume for TMO over the past 52 weeks.
| 52-week high | $643.99 |
|---|---|
| 52-week low | $435.27 |
| Volume | 1.56M |
| Average volume | 2.20M |
| Previous close | $627.55 |
Dividend history for Thermo Fisher Scientific over the trailing twelve months.
| Dividend yield | 0.29% |
|---|---|
| Dividend per share (TTM) | $1.80 |
| Payout ratio | 9.68% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.